miRNA-211 maintains metabolic homeostasis in medulloblastoma through its target gene long-chain acyl-CoA synthetase 4

Abstract The prognosis of childhood medulloblastoma (MB) is often poor, and it usually requires aggressive therapy that adversely affects quality of life. microRNA-211 (miR-211) was previously identified as an important regulator of cells that descend from neural cells. Since medulloblastomas primar...

Полное описание

Библиографические подробности

Главные авторы:	Menglang Yuan, Iqbal Mahmud, Keisuke Katsushima, Kandarp Joshi, Olivier Saulnier, Rudramani Pokhrel, Bongyong Lee, Wathsala Liyanage, Haritha Kunhiraman, Stacie Stapleton, Ignacio Gonzalez-Gomez, Rangaramanujam M. Kannan, Tanja Eisemann, Elayaraja Kolanthai, Sudipta Seal, Timothy J. Garrett, Saed Abbasi, Kimberly Bockley, Justin Hanes, Prem Chapagain, George Jallo, Robert J. Wechsler-Reya, Michael D. Taylor, Charles G. Eberhart, Animesh Ray, Ranjan J. Perera
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2023-12-01
Серии:	Acta Neuropathologica Communications
Предметы:	Medulloblastoma miRNA-211 Metabolism Nanoparticles Therapeutics
Online-ссылка:	https://doi.org/10.1186/s40478-023-01684-w
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!